3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasm Metastasis
2
Sarcoma, Synovial
1
Sarcoma
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Oropharyngeal Neoplasms
1
Neuroendocrine Tumors
1
Neoplasms
1
Mouth Neoplasms
1
Lymphatic Metastasis
1
Liposarcoma
1
Leukemia, Myeloid, Acute
1
Leiomyosarcoma
1
Laryngeal Neoplasms
1
Hypopharyngeal Neoplasms
1
Histiocytoma, Malignant Fibrous
1
Gliosarcoma
1
Glioblastoma
1
Gallbladder Neoplasms
1
Fallopian Tube Neoplasms
1
Dermatofibrosarcoma
1
Cholangiocarcinoma
1
Carcinoma
1
Interventions
Etoposide
30
Carboplatin
29
atezolizumab
17
durvalumab
16
Cisplatin
14
Topotecan
11
Specimen Handling
9
PM 01183
9
Magnetic Resonance Spectroscopy
7
pembrolizumab
6
olaparib
5
berzosertib
4
anlotinib
4
Radiotherapy
4
Nivolumab
4
Irinotecan
4
Drug Therapy
4
tremelimumab
3
toripalimab
3
tislelizumab
3
Paclitaxel
3
Injections
3
Docetaxel
3
Biopsy
3
Bevacizumab
3
AMG 757
3
sacituzumab govitecan
2
monalizumab
2
cabozantinib
2
Temozolomide
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Small Cell Lung Carcinoma
×
peposertib
×
90 days
×
Clear all
No trials found.